Major depressive symptoms in breast cancer patients with ovarian function suppression: a cross-sectional study comparing ovarian ablation and gonadotropin-releasing hormone agonists

Table 4 Clinical characteristics in breast cancer patients with major depressive symptoms

Characteristics	Major depressive symptoms (PHQ≥15)	Normal (PHQ<15)	χ² value	P Value
N	191	372
Age, years			1.624	0.202
≤ 45	118	209
> 45	73	163
Educational level			1.519	0.218
High school or below	84	184
College or above	107	188
Annual income (RMB)			0.157	0.692
≤ 50,000	133	265
> 50,000	58	107
Type of Surgery			13.969	<0.001
Mastectomy	129	304
Breast-conserving	62	68
TNM staging			0.019	0.890
I-III	135	265
IV	56	107
Hormone Receptor Status			0.039	0.843
ER or PR Positive	179	347
ER and PR Negative	12	25
HER2 Status			2.114	0.146
Positive	51	79
Negative	140	293
Type of OFS			4.442	0.035
GnRH agonist	121	268
Ovarian Ablation	70	104
OFS Time			0.059	0.809
≤ 2 years	116	222
> 2 years	75	150
OFS+ET			3.069	<0.080
AI/SERM	128/30	267/56
Ful	21	25
Sexual dysfunction			11.146	0.001
No	84	111
Yes	107	261

ISSN: 1471-244X